HomeBiotech

Biotech

Stoke Therapeutics, Biogen Report Long-Term Zorevunersen Data in Dravet Syndrome

Life Sciences Times - September 1, 2026

Biotech

NeuroSense Outlines Accelerated Development Strategy for PrimeC in ALS

Life Sciences Times - August 31, 2026

Biotech

Lilly to Acquire Merida Biosciences in Deal Worth Up to $2.875 Billion

Life Sciences Times - August 31, 2026

Biotech

TransCode Reports Preclinical Survival Benefit for TTX-MC138 in Breast Cancer Bone Metastasis

Life Sciences Times - August 31, 2026

Biotech

Alnylam Presents New RNAi Data Across ATTR-CM and Hypertension Programs

Life Sciences Times - August 31, 2026

Biotech

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Life Sciences Times - August 31, 2026 0

Biotech

CREATE Medicines, WestGene Partner to Advance In Vivo CAR Therapies

Life Sciences Times - August 28, 2026 0

Biotech

UCSF Researchers Build Largest Molecular Map of Autism, Identifying Potential Drug Targets

Life Sciences Times - August 28, 2026 0

Biotech

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

Life Sciences Times - August 28, 2026 0

Biotech

Natera, Angiex Partner to Evaluate AGX101 Treatment Response Using Signatera

Life Sciences Times - August 27, 2026 0

Biotech

Amgen Massachusetts Hosts 10th Annual Biotech Day for New England Scientists

Life Sciences Times - August 26, 2026 0

Biotech

Agenus Reports Updated Phase 2 NEST Data for BOT+BAL in Resectable Colon Cancer

Life Sciences Times - August 26, 2026 0

Biotech

Artis BioSolutions Opens Genetic Medicines Center in Spain With mRNA, LNP Manufacturing Capabilities

Life Sciences Times - August 26, 2026 0

Biotech

Outer Bio Launches Yuna Platform to Extend Viability of Ex Vivo Human Skin

Life Sciences Times - August 25, 2026 0

Biotech

Vyome Holdings Advances VT-1953 Program, Expands Pipeline in Second Quarter

Life Sciences Times - August 25, 2026 0

Biotech

Pretzel Therapeutics Advances PX578 Into Phase 2 Study for POLG Disease After FDA IND Clearance

Life Sciences Times - August 25, 2026 0

Biotech

Anbogen Therapeutics, University of Tokyo Partner to Evaluate ABT-301 Across Multiple Tumor Types

Life Sciences Times - August 24, 2026 0

12 3...109 Page 1 of 109

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

September 1, 2026

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

September 1, 2026

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

September 1, 2026

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

September 1, 2026

Biotech

Stoke Therapeutics, Biogen Report Long-Term Zorevunersen Data in Dravet Syndrome

NeuroSense Outlines Accelerated Development Strategy for PrimeC in ALS

Lilly to Acquire Merida Biosciences in Deal Worth Up to $2.875 Billion

TransCode Reports Preclinical Survival Benefit for TTX-MC138 in Breast Cancer Bone Metastasis

Alnylam Presents New RNAi Data Across ATTR-CM and Hypertension Programs

Most Read

Flosonics Medical Partners With BARDA on AI-Enabled Trauma Technology for FloPatch

Tobias Janowitz Named Director of Feinstein Institutes’ Cancer Research Institute

AstraZeneca Completes Global Licensing Deal for Lung Cancer Drug ZEGFROVY

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

EDITOR PICKS

Vertex Completes $10 Billion Acquisition of Crinetics, Expands Leadership Team

FDA Approves PharmaEssentia’s BESREMi for Adults With Essential Thrombocythemia

Agenus Publishes Phase 1b Data on BOT+BAL in Metastatic Colorectal Cancer

THIS WEEK'S STORIES

Natera, Angiex Partner to Evaluate AGX101 Treatment Response Using Signatera

Greater Boston Urology Adds Dr. Akash Sharma and Dr. Rafael Tua-Caraccia

Lilly to Acquire Merida Biosciences in Deal Worth Up to $2.875 Billion

POPULAR CATEGORY

ABOUT US

FOLLOW US